Sino-Life Group Limited (8296.HK)

HKD 0.54

(0.0%)

EBITDA Summary of Sino-Life Group Limited

  • Sino-Life Group Limited's latest annual EBITDA in 2023 was 1.69 Million CNY , down -79.72% from previous year.
  • Sino-Life Group Limited's latest quarterly EBITDA in 2024 Q2 was -3.83 Million CNY , down 0.0% from previous quarter.
  • Sino-Life Group Limited reported an annual EBITDA of 15.19 Million CNY in 2022, up 55.68% from previous year.
  • Sino-Life Group Limited reported an annual EBITDA of -4.27 Million CNY in 2021, down -21.6% from previous year.
  • Sino-Life Group Limited reported a quarterly EBITDA of -3.83 Million CNY for 2024 Q2, down 0.0% from previous quarter.
  • Sino-Life Group Limited reported a quarterly EBITDA of N/A for 2023 FY, down -79.72% from previous quarter.

Annual EBITDA Chart of Sino-Life Group Limited (2023 - 2007)

Historical Annual EBITDA of Sino-Life Group Limited (2023 - 2007)

Year EBITDA EBITDA Growth
2023 1.69 Million CNY -79.72%
2022 15.19 Million CNY 55.68%
2021 -4.27 Million CNY -21.6%
2020 12.45 Million CNY 183.99%
2019 4.38 Million CNY 202.57%
2018 -4.27 Million CNY 69.56%
2017 -13.34 Million CNY -0.71%
2016 -27.41 Million CNY -38833.33%
2015 -1.64 Million CNY 100.87%
2014 -4.12 Million CNY 51.47%
2013 -9.68 Million CNY 64.45%
2012 -23.9 Million CNY -1.84%
2011 -23.47 Million CNY -403.33%
2010 7.73 Million CNY -58.91%
2009 18.83 Million CNY 120.32%
2008 8.54 Million CNY 13.27%
2007 7.54 Million CNY 0.0%

Peer EBITDA Comparison of Sino-Life Group Limited

Name EBITDA EBITDA Difference
Anxian Yuan China Holdings Limited 106.4 Million HKD 98.407%
Water Oasis Group Limited 345.33 Million HKD 99.509%
Miricor Enterprises Holdings Limited 86.61 Million HKD 98.043%
Perfect Medical Health Management Limited 577.56 Million HKD 99.707%
Fameglow Holdings Limited 93.66 Million HKD 98.19%